Another hedgefund blogger. Kind of reminds me Seth Shaw.
The result of the final outcome with the FDA has not changed. Takeda and the FDA should be in a position in the near future to figure out the fate of Omontys. The data available for discussion is done. I sure there are a lot of issue to cover in the overall investigation. I am please to know Takeda is still working on the product.
Go to R & D development status July 31, 2013. Check the bottom page where Affymax is mentioned. Google the subject matter and read the report out of brazil. It's very technical. Then you might want to do a little research on Davita and the Mayo clinic.
The process has moved a step forward. Looking for resubmission now. Might want to read up on the latest publication report on the subject matter. Great read!!!!!
US big pharm does not want the science behind the drug to advance. The department of internal medicine in Germany has a different point of view.